Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns filed by MSD .
Filed returns
37
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| Jan–Apr 2026 | MSD | Economic Development and Industry | EU Pharmaceutical task Force (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2026 | MSD | Health | Engagement on Life Sciences and Innovation Policy (Public policy or programme) | 9 | On lobbying.ie |
| Jan–Apr 2026 | MSD | Health | Health Policy (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2025 | MSD | EU Affairs | EU Pharma Task Force (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2025 | MSD | Health | HPV catch-up vaccination programme (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2025 | MSD | Health | Healthcare Innovation (Public policy or programme) | 8 | On lobbying.ie |
| Sep–Dec 2024 | MSD | Health | Urban Waste Water Treatment Directive (Public policy or programme) | 4 | On lobbying.ie |
| Sep–Dec 2024 | MSD | Health | Health Policy Development for New Programme for Government (Public policy or programme) | 46 | On lobbying.ie |
| Jan–Apr 2024 | MSD | Health | EU Regulatory Data Protection Policy and Reimbursement Policy (Public policy or programme) | 3 | On lobbying.ie |
| Sep–Dec 2023 | MSD | Health | Access to Innovative Medicines (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2023 | MSD | Health | New medicines funding in Budget 2024 (Public policy or programme) | 7 | On lobbying.ie |
| Sep–Dec 2023 | MSD | Health | New medicines funding in Budget 2024 (Public policy or programme) | 7 | On lobbying.ie |
| Sep–Dec 2023 | MSD | Health | New medicines Funding in Budget 2024 (Public policy or programme) | 6 | On lobbying.ie |
| May–Aug 2023 | MSD | Health | Access to innovative cancer medicines (Public policy or programme) | 7 | On lobbying.ie |
| Jan–Apr 2023 | MSD | Health | Revision of the European Pharmaceutical Legislation (Public policy or programme) | 17 | On lobbying.ie |
| Sep–Dec 2022 | MSD | Economic Development and Industry | Positioning Ireland in the Global Biopharmaceutical Industry (Public policy or programme) | 7 | On lobbying.ie |
| May–Aug 2022 | MSD | Economic Development and Industry | Positioning Ireland in the Global Biopharmaceutical Industry (Public policy or programme) | 6 | On lobbying.ie |
| May–Aug 2021 | MSD | Health | Oncology Data Policy (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2020 | MSD | Health | Oncology Policy (Public policy or programme) | 34 | On lobbying.ie |
| May–Aug 2020 | MSD | Economic Development and Industry | Positioning Ireland in the Biopharmaceutical Industry (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2020 | MSD | Economic Development and Industry | Attendance at the World Economic Forum (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2019 | MSD | Economic Development and Industry | Attendance at the World Economic Forum (Public policy or programme) | 1 | On lobbying.ie |
| Sep–Dec 2019 | MSD | Economic Development and Industry | Positioning Ireland in the Biopharmaceutical Industry (Public policy or programme) | 4 | On lobbying.ie |
| May–Aug 2019 | MSD | Economic Development and Industry | Positioning Ireland in the Biopharmaceutical Industry (Public policy or programme) | 4 | On lobbying.ie |
| Jan–Apr 2019 | MSD | Health | Meeting request for an Taoiseach (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2019 | MSD | Economic Development and Industry | Attendance at the World Economic Forum (Public policy or programme) | 2 | On lobbying.ie |
| Sep–Dec 2018 | MSD | Economic Development and Industry | Briefing on expansion of MSD Carlow (Zoning or development) | 4 | On lobbying.ie |
| Sep–Dec 2018 | MSD | Health | Access to Innovative Medicines (Public policy or programme) | 14 | On lobbying.ie |
| Sep–Dec 2018 | MSD | Health | Attendance at the World Economic Forum (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2018 | MSD | Health | Innovation in Pharmaceuticals (Public policy or programme) | 2 | On lobbying.ie |
| Jan–Apr 2018 | MSD | Health | Attendance at the World Economic Forum (Public policy or programme) | 5 | On lobbying.ie |
| Sep–Dec 2017 | MSD | Economic Development and Industry | Attendance at the World Economic Forum (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2017 | MSD | Economic Development and Industry | Support for Foreign Direct Investment in Ireland by MSD (Public policy or programme) | 5 | On lobbying.ie |
| Jan–Apr 2017 | MSD | Economic Development and Industry | Attendance at World Economic Forum (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2017 | MSD | Economic Development and Industry | Continued support for MSD's presence in Ireland (Public policy or programme) | 7 | On lobbying.ie |
| Jan–Apr 2017 | MSD | Health | Immunisation Policy (Public policy or programme) | 18 | On lobbying.ie |
| Sep–Dec 2016 | MSD | Health | Attendance at World Economic Forum (Public policy or programme) | 1 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 22 | 59.5% | |
| Economic Development and Industry | 14 | 37.8% | |
| EU Affairs | 1 | 2.7% |